These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3089345)

  • 1. [The lack of generalized immunosuppression in C57BL/6 mice during progressive growth of syngenic T lymphoma EL-4 and Lewis lung carcinoma 3LL].
    Fuks BB; Malaĭtsev VV; Bogdanova IM
    Biull Eksp Biol Med; 1986 Jun; 101(6):725-8. PubMed ID: 3089345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors.
    Liu B; Podack ER; Allison JP; Malek TR
    J Immunol; 1996 Feb; 156(3):1117-25. PubMed ID: 8557987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of mitogen responses and graft-versus-host reaction by splenocytes from mice bearing Lewis lung carcinoma.
    Anaclerio A; Moras ML; Conti G; Mistrello G; Spreafico F
    J Natl Cancer Inst; 1978 Aug; 61(2):471-5. PubMed ID: 28421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal cytotoxic T lymphocyte hybridomas capable of specific killing activity, antigenic responsiveness, and inducible interleukin secretion.
    Kaufmann Y; Berke G
    J Immunol; 1983 Jul; 131(1):50-6. PubMed ID: 6190926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of proliferative and cytotoxic responses to interleukin 2 and concanavalin A in murine fetal thymus.
    Teh HS; Ho M
    J Immunol; 1985 Mar; 134(3):1653-8. PubMed ID: 3871454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence of immunomodulatory effects of cimetidine.
    Strejcek J; Suhajová E; Jíra M; Písa P
    Allerg Immunol (Leipz); 1984; 30(2):117-22. PubMed ID: 6237557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells].
    Chen J; Cao X; Xiu Q
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
    Asselin-Paturel C; Megherat S; Vergnon I; Echchakir H; Dorothée G; Blesson S; Gay F; Mami-Chouaib F; Chouaib S
    Cancer; 2001 Jan; 91(1):113-22. PubMed ID: 11148567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The murine IL 2 receptor. II. Monoclonal anti-IL 2 receptor antibodies as specific inhibitors of T cell function in vitro.
    Malek TR; Ortega G; Jakway JP; Chan C; Shevach EM
    J Immunol; 1984 Oct; 133(4):1976-82. PubMed ID: 6432904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
    Isakov N; Feldman M; Segal S
    Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
    Falk W; Männel DN; Dröge W
    J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of suppressor T cells in BCNU-mediated rejection of a syngeneic tumor.
    Nagarkatti M; Kaplan AM
    J Immunol; 1985 Aug; 135(2):1510-7. PubMed ID: 3159794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early loss of precursors of CTL and IL 2-producing cells in the development of neonatal tolerance to alloantigens.
    Carnaud C; Ishizaka ST; Stutman O
    J Immunol; 1984 Jul; 133(1):45-51. PubMed ID: 6233373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
    Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
    Gorelik E; Segal S; Feldman M
    J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and response to interleukin 2 in vitro and in vivo after bone marrow transplantation in mice.
    Merluzzi VJ; Welte K; Last-Barney K; Mertelsmann R; Souza L; Boone T; Savage DM; Quinn D; O'Reilly RJ
    J Immunol; 1985 Apr; 134(4):2426-30. PubMed ID: 3919093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.